Global Oligonucleotide Synthesis Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Drugs, Synthesized Oligo, Reagents, and Equipment.

By Type;

Custom, and Predesigned.

By Application;

Therapeutic Applications, Diagnostics, Research, and Others.

By End User;

Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn567257715 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Oligonucleotide Synthesis Market (USD Million), 2021 - 2031

In the year 2023, the Global Oligonucleotide Synthesis Market was valued at USD 4,554.40 million. The size of this market is expected to increase to USD 10,290.64 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 12.4%.

Oligonucleotides, short sequences of nucleotides, are pivotal in genetic testing, molecular diagnostics, and drug development. The surge in demand for personalized medicine, alongside advances in biotechnology and genomics, has significantly bolstered the market. With the increasing prevalence of genetic disorders and chronic diseases, there is a heightened need for precise and reliable diagnostic tools, further propelling the market forward. The advent of innovative technologies such as CRISPR-Cas9 and next-generation sequencing has revolutionized genetic research, leading to a higher demand for custom oligonucleotides.

Pharmaceutical and biotechnological companies are heavily investing in oligonucleotide-based therapies, including antisense oligonucleotides, small interfering RNAs (siRNAs), and aptamers, to address a wide range of medical conditions, from rare genetic diseases to cancer. Additionally, the rise of synthetic biology and the growing interest in synthetic genes and genome editing are contributing to the market's expansion. The continuous advancements in oligonucleotide synthesis technologies have resulted in higher purity, better accuracy, and faster synthesis processes, making these vital molecules more accessible and cost-effective.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Type
    3. Market Snapshot, By Application
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Global Oligonucleotide Synthesis Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Advancements in Biotechnology and Genomics

        2. Growing Demand for Personalized Medicine

        3. Increasing Prevalence of Genetic Disorders and Chronic Diseases

      2. Restraints
        1. High Cost of Oligonucleotide Synthesis

        2. Stringent Regulatory Requirements

        3. Limited Adoption in Developing Regions

      3. Opportunities
        1. Rising Investment in Oligonucleotide-Based Therapies

        2. Technological Innovations in Synthesis Processes

        3. Expansion of Synthetic Biology and Genome Editing Applications

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Oligonucleotide Synthesis Market, By Product, 2021 - 2031 (USD Million)
      1. Drugs

      2. Synthesized Oligo

      3. Reagents

      4. Equipment

    2. Global Oligonucleotide Synthesis Market, By Type, 2021 - 2031 (USD Million)
      1. Custom

      2. Predesigned

    3. Global Oligonucleotide Synthesis Market, By Application, 2021 - 2031 (USD Million)
      1. Therapeutic Applications
      2. Diagnostics
      3. Research
      4. Others
    4. Global Oligonucleotide Synthesis Market, By End User, 2021 - 2031 (USD Million)
      1. Academic Research Institutes
      2. Pharmaceutical and Biotechnology Companies
      3. Diagnostic Laboratories
      4. Others
    5. Global Oligonucleotide Synthesis Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Danaher Corporation
      2. Thermo Fisher Scientific Inc
      3. Merck KGaA
      4. Eurofins Scientific
      5. LGC Limited
      6. Agilent Technologies Inc
      7. Kaneka Corporation
      8. Maravai Lifesciences Holdings Inc
      9. Azenta Inc
  7. Analyst Views
  8. Future Outlook of the Market